RenovoRx

RenovoRx

Yahoo Finance • 18 days ago

Pre-Market Movers: TNGX, WOK, GOCO Set The Path

(RTTNews) - Biotech companies are seeing significant pre-market activity this Monday, hinting at possible breakout opportunities. Assessing sentiment and momentum in the premarket sets the tone for a trader's day. Price swings ahead of t... Full story

Yahoo Finance • last month

RenovoRx Announces Promising Pharmacokinetic Data Using the TAMP™ Platform Presented at the 2026 ASCO Annual Meeting

Sub-Study from Ongoing Phase III TIGeR-PaC Clinical Trial Supports TAMP for Targeted Intra-Arterial Delivery of Gemcitabine, Demonstrating Potential to Increase Local Drug Potency and Reduce Systemic Exposure and Common Side Effects MOUNT... Full story

Yahoo Finance • last month

RenovoRx (RNXT) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATE Thursday, May 14, 2026, at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Shaun R. BagaiChief Medical Officer and Executive Chair — Ramtin Agah, M.D.Chief Financial Officer — Mark Voll TAK... Full story

Yahoo Finance • 2 months ago

Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting

Data Shows TAMP to be a Promising Approach for Local Delivery of Gemcitabine with Reduced Systemic Toxicity in Patients Diagnosed with Locally Advanced Pancreatic Cancer Metabolic Imaging, Used to Evaluate Therapeutic Outcome Following Tr... Full story

Yahoo Finance • 3 months ago

RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026

RenovoRx, Inc. RenovoRx Joins the Ranks of Google, Nvidia, Adidas, Walmart, and More MOUNTAIN VIEW, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life-sciences company developin... Full story

Yahoo Finance • 3 months ago

After-Hours Earnings Report for March 30, 2026 : PRGS, PHR, DMAC, AIRJ, SPCE, HQI, SGMO, RNXT, INLX, FTHM

The following companies are expected to report earnings after hours on 03/30/2026. Visit our Earnings Calendar for a full list of expected earnings releases. Progress Software Corporation (PRGS)is reporting for the quarter ending Febru... Full story

Yahoo Finance • 3 months ago

RenovoRx announces $10 million private placement

* RenovoRx (RNXT [https://seekingalpha.com/symbol/RNXT]) announced on Wednesday the execution of definitive securities purchase agreements with institutional investors for an oversubscribed common stock and milestone warrant private plac... Full story

Yahoo Finance • 3 months ago

RenovoRx Announces $10 Million at Market Private Placement

Bolstered Cash Position Expected to Capitalize the Company’s Momentum Towards Important Milestones, Including Breakeven Operations and Trial Data Oversubscribed Financing Led by Leading Life Science Institutional Investors with Participat... Full story

Yahoo Finance • 6 months ago

Biotech Stocks Shine After Hours: Novo Nordisk, IDEAYA, Healthcare Triangle Among Gainers

(RTTNews) - Healthcare and biotechnology stocks saw notable moves in after-hours trading on Monday, with several companies posting strong gains despite limited news flow. Novo Nordisk A/S (NVO) surged in extended trading, climbing 9.48% t... Full story

Yahoo Finance • 6 months ago

RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026

MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented,... Full story

Yahoo Finance • 7 months ago

RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9th

MOUNTAIN VIEW, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (Nasdaq: RNXT) (“RenovoRx” or “the Company”), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA... Full story

Yahoo Finance • 7 months ago

RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th

MOUNTAIN VIEW, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (Nasdaq: RNXT) (“RenovoRx” or “the Company”), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA... Full story

Yahoo Finance • 7 months ago

RenovoRx GAAP EPS of -$0.08 in-line, revenue of $0.2M misses by $0.1M

* RenovoRx press release [https://seekingalpha.com/pr/20307315-renovorx-reports-third-quarter-2025-financial-results-including-approximately-900000-in-year] (RNXT [https://seekingalpha.com/symbol/RNXT]): Q3 GAAP EPS of -$0.08 in-line.... Full story

Yahoo Finance • 7 months ago

RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update

September 30, 2025 Cash and Cash Equivalents at $10 million Revenue Expected to Grow in 2026 and Continue to Offset Cash Burn Management to Host Conference Call Today at 4:30 p.m. ET MOUNTAIN VIEW, Calif., Nov. 13, 2025 (GLOBE NEWSWIR... Full story

Yahoo Finance • 8 months ago

Exploring 3 High Growth Tech Stocks in US Market

As the U.S. market grapples with a mix of earnings reports and renewed U.S.-China trade tensions, major stock indexes have been under pressure, with the tech-heavy Nasdaq and other indices closing lower. In this environment, identifying hi... Full story

Yahoo Finance • 9 months ago

RenovoRx’s PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites

First Registry-Eligible Patient Procedure Commenced at the University of Vermont Cancer Center Baptist Health Miami Cancer Institute and University of Pittsburgh Medical Center Join the University of Vermont Cancer Center as Participating... Full story

Yahoo Finance • 9 months ago

RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th

MOUNTAIN VIEW, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented,... Full story

Yahoo Finance • 10 months ago

Curious about the stocks that are showing activity after the closing bell on Wednesday?

As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. [postmarket] GAINERS TICKER CHANGE COMMENT... Full story

Yahoo Finance • 11 months ago

RenovoRx expands commercial footprint to 13 cancer centers

MOUNTAIN VIEW, Calif. - RenovoRx, Inc. (NASDAQ:RNXT), a medical device company with a market capitalization of $44.6 million and strong balance sheet showing more cash than debt, has expanded its commercial footprint to 13 cancer centers a... Full story

Yahoo Finance • 11 months ago

RenovoRx Expands U.S. Commercialization Efforts for the RenovoCath® Device with Growing Customer Demand and Key Leadership Hire

RenovoRx increases its commercial footprint to thirteen leading National Cancer Institute-designated and community centers approved to purchase RenovoCath Four active cancer center customers are currently purchasing and have made repeat o... Full story